Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Vilin Bio Med Financial Results

Vilin Bio Med reported its FY2026 audited financial results following board approval. The company maintained steady operations with no reported deviations in fund utilization.

Source

NSE filing, NSE: VILINBIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Vilin Bio Med Ltd: key numbers

Share price
₹50.85
Market cap
₹77.55 Cr
Revenue (annual)
₹42.26 Cr
Net profit (annual)
₹1.93 Cr
P/E (TTM)
40.2×Sector 46.1×
Promoter holding
56.65%+0.00% QoQ
FII holding
0.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Vilin Bio Med Ltd

All →

Other financial results announcements

All →